[go: up one dir, main page]

ZA200807802B - Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis - Google Patents

Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis

Info

Publication number
ZA200807802B
ZA200807802B ZA200807802A ZA200807802A ZA200807802B ZA 200807802 B ZA200807802 B ZA 200807802B ZA 200807802 A ZA200807802 A ZA 200807802A ZA 200807802 A ZA200807802 A ZA 200807802A ZA 200807802 B ZA200807802 B ZA 200807802B
Authority
ZA
South Africa
Prior art keywords
metabolism
lipolysis
compositions
methods
lipolytic
Prior art date
Application number
ZA200807802A
Other languages
English (en)
Inventor
Heuer Marvin
Chaudhuri Shan
Clement Ken
Original Assignee
Hhc Formulations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hhc Formulations Ltd filed Critical Hhc Formulations Ltd
Publication of ZA200807802B publication Critical patent/ZA200807802B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/18—Extraction of water soluble tea constituents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/754—Evodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200807802A 2006-03-08 2008-09-10 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis ZA200807802B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78074106P 2006-03-08 2006-03-08

Publications (1)

Publication Number Publication Date
ZA200807802B true ZA200807802B (en) 2009-10-28

Family

ID=38474575

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807802A ZA200807802B (en) 2006-03-08 2008-09-10 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis

Country Status (7)

Country Link
US (2) US7935367B2 (xx)
EP (1) EP1991243A1 (xx)
AU (1) AU2007222860A1 (xx)
CA (1) CA2643385A1 (xx)
MX (1) MX2008011501A (xx)
WO (1) WO2007101349A1 (xx)
ZA (1) ZA200807802B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196515A1 (en) * 2006-02-22 2007-08-23 Kothari Shil C Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome X
AU2007341056A1 (en) * 2006-07-07 2008-07-10 Avestha, Gengraine, Technologies, Pvt., Ltd. Cissus quadrangularis plant extracts for treating osteoporosis and the extraction process thereof
US20090155442A1 (en) * 2007-12-18 2009-06-18 Multi Formulations Ltd. Method for enhancing delivery and uniformity of concentration of dietary ingredients
WO2009076742A1 (en) * 2007-12-18 2009-06-25 Multi Formulations Ltd. Effervescent dietary composition for enhancing delivery of dietary ingredients
US8663714B2 (en) 2009-11-26 2014-03-04 D.Xign Limited Appetite regulating dietary supplement
KR100992995B1 (ko) * 2010-05-03 2010-11-09 연세대학교 산학협력단 피페로날의 신규한 용도
CN102933099B (zh) * 2010-06-04 2015-06-24 荷兰联合利华有限公司 含有儿茶素类的产品
FR2966040A1 (fr) * 2010-10-19 2012-04-20 Brigitte Gourlaouen Composition amincissante et/ou de prevention des processus inflammatoires
US20150004282A1 (en) * 2012-01-09 2015-01-01 Pacific Shore Holdings, Inc. Dietary supplements containing caffeine and niacin
CN104837496A (zh) * 2012-11-21 2015-08-12 荷兰联合利华有限公司 包含茶氨酸和总状土木香提取物的组合物
CN104837371A (zh) 2012-12-13 2015-08-12 荷兰联合利华有限公司 可食用组合物
WO2021096882A1 (en) * 2019-11-11 2021-05-20 Nusirt Sciences, Inc. Compositions, methods and kits for altering adipocytes
WO2025243087A2 (en) * 2024-05-24 2025-11-27 Athletic Greens International, Inc. Compositions, methods of using same, and kits comprising same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610136D0 (en) * 1996-05-15 1996-07-24 Rio Pharmaceuticals Ltd Pharmaceutical compositions
CN1195269A (zh) * 1996-06-12 1998-10-07 协和发酵工业株式会社 脂质代谢改善剂
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
US6322826B2 (en) * 1998-06-16 2001-11-27 Mathias Christian Zohoungbogbo Dietetic food composition and dietetic method using such composition
AU784660B2 (en) * 1999-10-19 2006-05-18 Curagen Corporation Genes associated with obesity and methods for using the same
AU2003228603A1 (en) * 2002-04-22 2003-11-10 Rtc Research And Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
US20040005368A1 (en) * 2002-07-01 2004-01-08 Morris Mann Novel approach to weight loss comprising a modified protein composition that regulates blood sugar in conjunction with compositions that increase oxygen uptake and suppress appetite
CN1568731A (zh) * 2003-07-25 2005-01-26 毛保民 一种槐豆茶及其制取方法
KR100449887B1 (ko) * 2003-10-31 2004-09-22 주식회사 렉스진바이오텍 이소플라본을 함유하는 괴각 추출물의 제조방법
US20060013903A1 (en) * 2004-07-16 2006-01-19 Timothy Romero Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss
US20050245434A1 (en) * 2004-04-30 2005-11-03 Shibnath Ghosal Oxygenated dibenzo-alpha-pyrone chromoproteins
CA2565154A1 (en) * 2004-05-03 2005-11-24 Duke University Compositions for affecting weight loss
US20060148727A1 (en) * 2004-12-01 2006-07-06 Curt Hendrix Folate based composition for neurological and cognitive applications
CN1663563A (zh) * 2005-02-04 2005-09-07 北京阜康仁生物制药科技有限公司 复方曲克芦丁和吡拉西坦制剂及其应用
US20070196515A1 (en) * 2006-02-22 2007-08-23 Kothari Shil C Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome X
KR100862968B1 (ko) * 2007-02-21 2008-10-13 바이오스펙트럼 주식회사 마트린 또는 옥시마트린을 포함하는 피부 주름 개선제

Also Published As

Publication number Publication date
US7955624B2 (en) 2011-06-07
US7935367B2 (en) 2011-05-03
WO2007101349A1 (en) 2007-09-13
CA2643385A1 (en) 2007-09-13
EP1991243A1 (en) 2008-11-19
AU2007222860A1 (en) 2007-09-13
MX2008011501A (es) 2009-01-07
US20070212429A1 (en) 2007-09-13
US20080152732A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
ZA200807802B (en) Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
IL250678A0 (en) Compounds and methods for repressing pcsk9 gene expression
HRP20170347T1 (hr) Pripravci i postupci za uporabu za protutijela protiv sklerostina
PL2578081T4 (pl) Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
EP2041267A4 (en) COMPOSITIONS AND METHODS FOR INCREASING THE USE OF GLYCEROL
AP2011005681A0 (en) Methods and formulations for treating chronic liver disease.
PL2234621T3 (pl) Kompozycje i sposoby leczenia chorób paznokcia
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL193297A0 (en) Imidazole-based compounds, compositions comprising them and methods of their use
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
ZA200900140B (en) Methods and compositions for treating biofilms
EP2355660A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
PL2293670T3 (pl) Kompozycje i sposoby leczenia grzybicy paznokci
GB0718918D0 (en) Compositions and methods for treating skin conditions
WO2009158387A3 (en) Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
EP2094279A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
WO2010007528A3 (en) Biomarkers for insulin efficacy
ZA201001779B (en) Compositions and methods for treating collagen-mediated diseases
HK1126402A (en) Compositions and methods for treating conditions of the nail unit